Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by torpedomanon Mar 02, 2015 4:04pm
153 Views
Post# 23481428

RE:RE:RE:Zenith?

RE:RE:RE:Zenith?Jbuffett

Are you from Margaritaville? Love that place and the music. 
I brought up the $ 8 - $ 9 number because that would give me a very tidy profit and cement my retirement package. In reality if RVX208 does what it is supposed to do in the Ph 3 the price should be way higher - say $ 25 to $ 30.00USD per share. But we must remember it is only worth what someone will pay for it as with anything.
I do not understand the reluctance of BP on RVX unless Don is asking too much and annoyed them or they are too preoccupied with their own businesses or they see RVX208 as a threat to their existing products/research. This may imply collusion. I worked for Pfizer for 13 years and you never know. I mean this has the potential to make all other heart drugs superfluous.  
As to how a deal would be structured there are all kinds of possiblities - licensing, upfront cash with milestone payments, etc. I think Don and Dart would prefer an all cash deal but beggars can't be choosers. If half was Pfizer shares for example I would be quite content with that. Pfizer is sitting on something like $ 60B in cash - a $ 9 price is a drop in the bucket for them.
Why sell to BP - a number of reasons. The BPs have worldwide sales organizations with established clients. They have the money for multi-media advertising which is a relatively recent phenomenen. They have political lobbyists to smooth the road through regulatory and market acceptance. RVX simply does not have the resources to take this product to market and never will except in a possible partnership with BP. Ken Dart is worth close to $ 7B but I doubt even he could take it all the way.    
What would the stock be worth if RVX tried to take it to market - probably less than it is worth now.
They NEED a deep-pocketed buyer/partner. Who besides existing shareholders and a few people in Calgary have even heard of RVX?  Don says he is having discussions with BP and has described them as " ongoing" " substantive " serious" etc and he said at the 2012 AGM that he would have his choice of partners after Assure. When Assure failed I think a lot of BP headed for the hills. They really need to get the word out about positive MACE and they are tryiing hard to do that.      
They already have a rich benefactor in Dart. We don't know entirely his motives for backing the big loan from Citibank but he may continue to bankroll Don.
I don't mean to be negative. I just want to give you a realistic perspective. I am very positive about RVX and believe it can be a 10 or 20 banger. You will need much patience and a potentially long investment window. Do not bet the farm on it. I have a friend here who did and is deeply regetting the move since he has come on some hard times. It has taken me on a long and winding road for almost 12 years and I am getting weary of it. Hopefully you won't have that long to wait.
Always DYODD  

Torpedoman       

Bullboard Posts